CGRP Education & Research Forum
Already a member? Become a member Register

Australia: Three-centre experience confirms erenumab benefits

Real world experience from three headache centres in Australia has supported the beneficial effects of erenumab in chronic migraine. Of 170 patients with chronic migraine who were prescribed erenumab 70 or 140 mg, 100 (58.8%) had a > 50% reduction in monthly migraine days at three months, and 79 (46.5%) had a > 50% reduction …

Read more »